Co-Founder/CFO/Creator of SandersteadCCTV/Ex-PwC
PC
Precision Clinical Intelligence Ltd.
precisionclinicalintelligence.com
Website unreachable since Oct 31, 2026
This startup provides an AI-powered platform that analyzes clinical trial data to generate new insights for healthcare professionals. By leveraging machine learning, the platform helps physicians improve patient outcomes through enhanced data analysis.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for quantifying patient response to monoclonal antibody treatments often lack precision and efficiency. This can lead to delays in treatment adjustments and suboptimal patient outcomes.
Solution
Precision Clinical Intelligence offers MABVIEWER, a Software-as-a-Medical Device (SaMD) platform that combines molecular imaging technology with proprietary algorithms to precisely quantify a patient's response to monoclonal antibody therapy. The platform analyzes molecular imaging data to provide physicians with detailed, quantitative insights into treatment effectiveness. By leveraging patented algorithms, MABVIEWER aims to accelerate and transform patient outcomes by providing healthcare professionals with access to precision data. This enables more informed clinical decision-making and personalized treatment strategies.
Target Audience
The primary users are healthcare professionals, specifically physicians, who prescribe and monitor monoclonal antibody treatments.
Features
- Combines existing molecular imaging technology with patented algorithms.
- Quantifies patient response to monoclonal antibody treatments.
- Provides physicians with precision data to inform clinical decisions.
- Software-as-a-Medical Device (SaMD) platform.